Gut bugs may influence cancer treatment success
NCT ID NCT07407218
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at 58 head and neck cancer patients receiving standard radiotherapy. Researchers collected stool and blood samples to see if gut bacteria and their byproducts are linked to how well the treatment works and how severe side effects are. The goal is to find clues that could one day help personalize care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this research could help doctors personalize supportive care during radiotherapy to improve outcomes and reduce side effects.
- What could go wrong
- This is a small, completed observational study, not a treatment trial. It only looks for associations, so it cannot prove cause and effect.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD AND NECK CANCER (H&N) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Institute of Oncology Ljubljana
Ljubljana, 1000, Slovenia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Brain games may rev up thinking and driving after cancer treatment
- New imaging tracer could spot hidden cancers and fibrosis in one scan
- Heat and pulses: new combo therapy aims to soften cancer Treatment's harsh toll
- Bacteria in the mouth and gut may predict who responds to cancer immunotherapy
- Glowing dye may save surgical flaps in head and neck cancer patients
- New radioactive tracers could spot cancers more clearly